Latest papers

Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa.

Levodopa Improves Procedural Motor Learning in Chronic Stroke Patients

The hydrosoluble fiber Plantago ovata husk improves levodopa (with carbidopa) bioavailability after repeated administration.

Altered behavioural and neurochemical profile of L-DOPA following deuterium substitutions in the molecule.

Simultaneous determination of levodopa and carbidopa by synchronous fluorescence spectrometry using double scans.

Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.

Flow-batch technique for the simultaneous enzymatic determination of levodopa and carbidopa in pharmaceuticals using PLS and successive projections algorithm.

Dopa-responsive dystonia presenting as delayed and awkward gait.

Should levodopa dose be reduced when switched to stalevo?

Acute overdose with controlled-release levodopa-carbidopa.

L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.

[The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life].

Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-o-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg : randomized, double-blind, placebo-controlled, crossover study in healthy subjects.

[The clinical-pharmacoeconomic study of efficacy of stalevo in the treatment of Parkinson's disease with motor fluctuations].

Pathological hypersexuality induced by dopamine replacement therapy in a patient with progressive supranuclear palsy.

Effects of nebicapone on levodopa pharmacokinetics, catechol-O-methyltransferase activity, and motor fluctuations in patients with Parkinson disease.

Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.

Simultaneous kinetic-spectrophotometric determination of carbidopa, levodopa and methyldopa in the presence of citrate with the aid of multivariate calibration and artificial neural networks

Role of the pharmacist in the effective management of wearing-off in Parkinson's disease.

The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.